Medtronic Partners with University of Colorado to Accelerate Healthcare Innovation in AI, Robotics, and Sustainability
Key Insights
Medtronic has established its second academic strategic partnership with CU Anschutz Innovations (search) following a nationwide search for leading healthcare innovation institutions.
The long-term collaboration spans three University of Colorado campuses and focuses on breakthrough solutions in artificial intelligence, robotics, and sustainability.
The partnership aims to accelerate the translation of academic discoveries from lab to bedside, delivering faster patient benefits through enhanced commercialization pathways.
Global healthcare technology leader Medtronic has forged a strategic research agreement with CU Anschutz Innovations (search) to accelerate the development of novel health technologies. The University of Colorado team was selected from a nationwide search for academic institutions positioned to lead the future of healthcare innovation, marking Medtronic's second academic strategic partnership.
The long-term collaboration spans across CU Anschutz (search), CU Boulder (search), and CU Denver (search), leveraging the diverse expertise and innovation strengths of each campus to address pressing health challenges. The partnership was formally launched at a joint summit event at CU Anschutz on January 22, 2026, where priority research projects and initiatives for advancement were identified.
Strategic Focus Areas
The collaboration will initially concentrate on three transformative areas aligned with Medtronic's global technology strategy: sustainability, robotics, and artificial intelligence. These disruptive healthcare domains represent critical frontiers for advancing patient care and addressing unmet medical needs.
"This agreement represents a bold step forward in how academic institutions and industry leaders can work together to drive meaningful innovation," said Kim Muller, vice chancellor for innovation and biotechnology at CU Anschutz (search) and executive director of CU Anschutz Innovations (search). "By leveraging the strengths of our campuses and aligning with the Medtronic mission, we are creating a powerful platform for discovery and impact."
Accelerating Translation to Clinical Practice
The partnership aims to deliver technologies that move from lab to bedside faster, bringing real benefits to patients through enhanced translation pathways. CU Anschutz Innovations (search) serves as the medical campus's hub for innovation and entrepreneurship, connecting researchers, clinicians, and industry partners to accelerate groundbreaking healthcare solution development.
"We are thrilled to welcome the University of Colorado as our newest academic strategic research partner," said Jim Peichel, chief technology officer at Medtronic. "Together, we will explore new frontiers that are critical to the future of healthcare and to the Medtronic mission of alleviating pain, restoring health and extending life."
Institutional Commitment to Innovation
The collaboration reflects the University of Colorado's continued leadership in research and innovation, demonstrating its dedication to fostering collaborative relationships that translate academic excellence into real-world solutions. Through intellectual property and licensing support, strategic partnerships, and commercialization resources, the initiative transforms academic discoveries into practical applications that improve patient care and advance global health.
"This initiative brings together CU Anschutz (search)'s strengths in health sciences research with industry insights to address key challenges in healthcare — from sustainability to robotics and data-driven innovation," said John H. Sampson, MD, PhD, MBA, University of Colorado Anschutz vice chancellor for health affairs and dean of CU Anschutz School of Medicine (search). "It's an exciting step toward our mission of bringing innovative technologies from the lab to the bedside, delivering real benefits to patients more swiftly and effectively."